Does Diabetes Mellitus Abolish the Beneficial Effect of Primary Coronary Angioplasty on Long-term Risk of Reinfarction After Acute ST-Segment Elevation Myocardial Infarction Compared With Fibrinolysis? (A DANAMI-2 Substudy) Mette M. Madsen, MD, Martin Busk, MD, Hanne M. Søndergaard, MD, Morten Bøttcher, MD, Leif S. Mortensen, MSc, Henning R. Andersen, MD, Torsten T. Nielsen, MD American Journal of Cardiology Volume 96, Issue 11, Pages 1469-1475 (December 2005) DOI: 10.1016/j.amjcard.2005.07.053 Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 1 Cumulative combined event rate (A) and cumulative reinfarction rate (B) for the 4 groups (diabetic patients treated with angioplasty, diabetic patients treated with fibrinolysis, nondiabetic patients treated with fibrinolysis, and nondiabetic patients treated with angioplasty). The p values apply for comparison across 4 groups. American Journal of Cardiology 2005 96, 1469-1475DOI: (10.1016/j.amjcard.2005.07.053) Copyright © 2005 Elsevier Inc. Terms and Conditions